DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 41.00
+0.05 (0.12%)
Jun 18, 2026, 2:49 PM CST
DV Biomed Market Cap
DV Biomed has a market cap or net worth of 998.32 million as of June 18, 2026. Its market cap has decreased by -41.71% in one year.
Market Cap
998.32M
Enterprise Value
722.04M
Revenue
794.18M
Ranking
n/a
PE Ratio
124.24
Stock Price
41.00
Market Cap Chart
Since October 15, 2015, DV Biomed's market cap has decreased from 5.01B to 998.32M, a decrease of -80.06%. That is a compound annual growth rate of -14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 998.32M | -30.51% |
| Dec 31, 2025 | 1.44B | 11.93% |
| Dec 30, 2024 | 1.28B | -55.96% |
| Dec 29, 2023 | 2.91B | -11.33% |
| Dec 30, 2022 | 3.29B | -5.52% |
| Dec 30, 2021 | 3.48B | -17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.93B |
| GeneFerm Biotechnology | 1.40B |
| InnoPharmax | 1.29B |
| Excelsior Biopharma | 1.14B |
| Prince Pharmaceutical | 1.13B |
| Winston Medical Supply | 1.11B |
| Anxo Pharmaceutical | 949.81M |
| Mediera | 900.26M |